Document Detail


Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure.
MedLine Citation:
PMID:  21947989     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: Levosimendan (L) is used in clinical practice for the treatment of severe heart failure (HF); it has inotropic and vasodilatory effects, without increasing myocardial oxygen consumption. In acute HF, levosimendan improves hemodynamic parameters; previous studies have demonstrated that it has favorable effects on left ventricular (LV) diastolic function. The aim of our study was to evaluate the effect of on LV long-axis function that represents the earlier marker of diastolic dysfunction. Methods: We enrolled 41 patients (age 62 ± 12 years) admitted to our Department for acute HF, NYHA class IV and severe LV dysfunction. Twenty-six patients were treated with L (0.1 μg/kg/min ev for 24 h without loading dose) and 15 patients were treated with standard therapy (C). We evaluated clinical, blood exams and echocardiographic parameters at baseline and one week after L or C treatment. Results: Baseline demographic, clinical and biochemical data were similar in both groups. After one week, the L group had shown a significant improvement in NYHA class and a reduction of pro-B-type natriuretic peptide (pro-BNP). In echocardiographic study, we observed an improvement in LV longitudinal function (p 〈 0.05) and LV ejection fraction (p 〈 0.05) with a reduction of E/E' (p 〈 0.05) in the L group. We divided the L group into ischemic and non- -ischemic patients and we demonstrated a significant increase in systolic function in the former. No differences were found between subgroups in diastolic function. Conclusions: L therapy, without loading dose, improves NYHA class and ventricular function in patients with acute HF; we believe that these prolonged hemodynamic effects are due to active metabolities of L. (Cardiol J 2011; 18, 5: 532-537).
Authors:
Stefano Lunghetti; Elisabetta Palmerini; Rossella Urselli; Silvia Maffei; Elisa Guarino; Marta Focardi; Sergio Mondillo; Roberto Favilli
Related Documents :
21663949 - The effects of lowering ldl cholesterol with simvastatin plus ezetimibe in patients wit...
22402419 - Arrhythmia and sleep-disordered breathing in patients undergoing cardiac surgery.
11329759 - Angiotensin ii-receptor blockers: clinical relevance and therapeutic role.
21097669 - Clinical applications of bivalirudin in the cardiac catheterization laboratory.
22521309 - Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortalit...
17804969 - Improved treatment of hospitalized coronary artery disease patients with the get with t...
21891819 - Desperate times, desperate measures: rotablating dissections in acute myocardial infarc...
12067939 - Regional left ventricular function during transient coronary occlusion: relation with c...
7588939 - Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic t...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiology journal     Volume:  18     ISSN:  1897-5593     ISO Abbreviation:  Cardiol J     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101392712     Medline TA:  Cardiol J     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  532-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycard...
Next Document:  Relationship between R-R interval variation and left ventricular function in sinus rhythm and atrial...